DiI HDL NP treatment of Jurkat cells, a SCARB1-negative T cell leukemia/lymphoma cell line, did not result in increased fluorescent signal over baseline (Fig. S1, C), confirming that the HDL NPs target SCARB1 in B cell lymphoma. Here, SCARB1 is linked to B-cell non-Hodgkin lymphoma.